Medfinder
Back to blog

Updated: January 29, 2026

What Is Imiquimod? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Medication cream tube with information icon and educational elements

Imiquimod is a topical immune-modifying cream used for genital warts, actinic keratosis, and basal cell carcinoma. Here's everything you need to know about uses, dosing, and how to use it.

Imiquimod is a prescription topical cream that works by harnessing your own immune system to fight certain abnormal skin conditions. Unlike many medications that directly attack viruses or cancer cells, imiquimod takes a different approach — it activates the body's local immune defense. This guide covers everything you need to know: what imiquimod treats, how it's used, what to expect, and key safety information for 2026.

What Is Imiquimod?

Imiquimod is a synthetic immune response modifier — it belongs to a class called imidazoquinolines. It was first approved by the FDA in 1997 and is available as a cream in three concentrations: 2.5%, 3.75%, and 5%. Brand names include Zyclara (3.75% and 2.5%) while the original brand Aldara (5%) has been discontinued — though the generic 5% cream is widely available.

Imiquimod is not a chemotherapy agent, antiviral, or antibiotic in the traditional sense. It doesn't directly destroy viruses or cancer cells. Instead, it stimulates your immune system's response at the site of application, essentially recruiting your body's own defense mechanisms to clear abnormal tissue.

What Is Imiquimod Used For?

Imiquimod is FDA-approved for three distinct conditions:

1. External Genital and Perianal Warts (Condyloma Acuminata)

Genital warts are caused by certain strains of human papillomavirus (HPV). Imiquimod stimulates the immune system to recognize and attack HPV-infected skin cells, causing the warts to shrink and clear. It is approved for use in patients 12 years of age and older. Important: imiquimod does not cure HPV, and new warts may appear after treatment. It does not prevent HPV transmission.

2. Actinic Keratosis (AK)

Actinic keratoses are rough, scaly patches on the skin caused by years of UV exposure. They are precancerous — if untreated, some can progress to squamous cell carcinoma. Imiquimod is approved for treatment of clinically typical, nonhyperkeratotic, nonhypertrophic AK on the face or balding scalp in immunocompetent adults. It's particularly useful for "field treatment" of multiple AK lesions in an area.

3. Superficial Basal Cell Carcinoma (sBCC)

Superficial basal cell carcinoma is the most common form of skin cancer. Imiquimod (5%) is approved for biopsy-confirmed, primary sBCC in immunocompetent adults, for tumors up to 2 cm in diameter on the trunk (excluding anogenital skin), neck, or extremities (excluding hands and feet). Studies show complete clearance rates of approximately 80–90% for eligible lesions. A biopsy is required to confirm the diagnosis before treating with imiquimod.

How Is Imiquimod Used? (Dosing by Indication)

Dosing varies by indication and strength. Always follow your doctor's instructions exactly. The general schedules are:

Genital warts (5% cream): Apply 3 times per week (e.g., Monday/Wednesday/Friday) at bedtime; leave on 6–10 hours; wash off with mild soap; continue until warts clear, up to 16 weeks maximum.

Genital warts (3.75% Zyclara): Apply once daily at bedtime; leave on ~8 hours; wash off; continue for up to 8 weeks or until warts clear.

Actinic keratosis (3.75% Zyclara): Apply once daily at bedtime to entire face or scalp for two 2-week cycles separated by a 2-week rest period; leave on ~8 hours; wash off.

Actinic keratosis (5% cream): Apply twice weekly for 16 weeks to one defined treatment area; leave on ~8 hours; wash off.

Superficial BCC (5% cream): Apply 5 times per week (5 days on, 2 days off) at bedtime for 6 weeks; leave on ~8 hours; wash off.

How to Apply Imiquimod: Step-by-Step

Wash hands and the treatment area with mild soap and water. Pat dry.

Apply a thin layer of cream to the affected area. Rub in gently until no longer visible.

Do not cover the treated area with bandages or waterproof dressings. Cotton gauze or underwear is okay.

Leave on overnight for the prescribed number of hours (usually 6–10 hours).

In the morning, wash the treated area with mild soap and water. Wash your hands again.

Discard any open single-use packet — do not save or reuse it.

Important Warnings

Do not apply inside the vagina, anus, or to the eyes, nose, or mouth

Imiquimod weakens latex condoms and diaphragms — avoid these while cream is on the skin

Avoid sun exposure to treated areas — use protective clothing or sunscreen

Avoid sexual contact while cream is on the skin

Use with caution if you have autoimmune conditions or are on immunosuppressive therapy — discuss with your doctor

For a detailed review of what side effects to expect, see our complete guide to imiquimod side effects.

If you're having trouble finding imiquimod at a pharmacy near you, use medfinder.com to locate confirmed in-stock locations without calling pharmacies yourself.

Frequently Asked Questions

Imiquimod is FDA-approved for three conditions: external genital and perianal warts (condyloma acuminata) caused by HPV in patients 12 and older, actinic keratosis on the face or scalp in adults, and superficial basal cell carcinoma on the trunk, neck, or extremities in adults. It is also used off-label for molluscum contagiosum and common warts.

Imiquimod treatment timelines vary by indication. For genital warts, warts may begin to respond within 4–6 weeks, with treatment continuing up to 16 weeks. For actinic keratosis, the full course takes 4–6 weeks depending on the regimen. For superficial basal cell carcinoma, the 6-week treatment course is followed by a 12-week post-treatment assessment to evaluate clearance.

No. Imiquimod is not a DEA-scheduled controlled substance. It can be prescribed by any licensed prescriber — including via telehealth — without special permits or DEA registration.

Imiquimod can clear visible genital warts, but it does not cure HPV. The virus can remain in the body even after warts are treated, and new warts may appear after treatment. Imiquimod also does not prevent HPV transmission to sexual partners.

Yes — imiquimod is specifically approved for actinic keratosis treatment on the face and scalp. However, it should not be used on facial areas with broken skin, near the eyes, nose, or lips, or on the face for conditions other than AK without your doctor's guidance. The 3.75% Zyclara formulation is commonly used for facial AK.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Imiquimod also looked for:

37,258 have already found their meds with Medfinder.

Start your search today.

37K+
5-star ratingTrusted by 37,258 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?